INS and type 2 diabetes mellitus: Currently, there are many treatments for T2D, but there are still problems such as insufficient efficacy and good response, such as sulphonylurea and insulin, which are highly associated with increased risks of cardiovascular disease, hypoglycemia, and diabetic ketoacidosis [15,16].